| Literature DB >> 23029386 |
Hendy Abdoul1, Christophe Perrey, Philippe Amiel, Florence Tubach, Serge Gottot, Isabelle Durand-Zaleski, Corinne Alberti.
Abstract
BACKGROUND: Peer review of grant applications has been criticized as lacking reliability. Studies showing poor agreement among reviewers supported this possibility but usually focused on reviewers' scores and failed to investigate reasons for disagreement. Here, our goal was to determine how reviewers rate applications, by investigating reviewer practices and grant assessment criteria. METHODS ANDEntities:
Mesh:
Year: 2012 PMID: 23029386 PMCID: PMC3460995 DOI: 10.1371/journal.pone.0046054
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Guidelines for peer review of grant applications issued by the eight French Academic Hospital Research Grant Agencies.
| National PHRC | Paris PHRC | North West PHRC | East PHRC | West PHRC | South West PHRC (for methodologists) | South West PHRC (fornon- methodologist) | Rhone Alpes PHRC | |
|
| ||||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Scoring method | Numerical | Alphabetical | Numerical | Numerical | Numerical | Numerical | Numerical | Alphabetical |
| Range of score |
| A, B, C,D, E |
| [0–20] |
| [14–56] |
| A+, A−, B, C, Other |
| Sum of individual criterion scores | Yes | No | Yes | Yes | Yes | Yes | Yes | No |
| Decision of funding based onproposals score | Yes | No | Yes | Yes, [0–10]: reject | No | No | No | Yes, A+, excellent;A−, Good; B, Fair; C, Insufficient |
|
| ||||||||
| Scoring grid supplied | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Scoring method | Numerical | Qualitative | Numerical | Numerical | Numerical | Numerical | Numerical | Alphabetical |
| Score ranking |
| Poor, Fair, Good, Excellent |
| [0–5] |
|
|
| A+, A−, B, C, Other |
| Weighting of criteria | No | No | No | No | No | Yes | No | No |
| Sum of individual criterion or itemscores | No | No | No | No | Yes | No | Yes | |
|
|
|
|
|
|
|
|
| |
| Guidelines about the scoring method | Yes, 1: theworse, 3: thebest | Yes 1,insufficient;2, fair; 3,good; 4,excellent | Yes 0, very inadequate; 1, inadequate, 2,open to criticism,3, acceptable;4,very good; 5, excellent | Yes 4, best possible score;1, worst possible score | Yes 1, worst possiblescore; 4, best possible score | Yes 1, worst possiblescore; 4, best possible score | Yes A+, excellent; A−, Good; B, Fair; C, Inadequate; Other, Out of scope of review | |
|
| Mandatory | Mandatory | Mandatory | Mandatory | Mandatory | Optional | Mandatory | Optional |
| Structured report | No | No | No | No | No | No | Yes | No |
Guidelines for peer review of grant applications issued by one French national and five international funding organizations.
| ANR | NIH | MRC | ESF | CIHR | NHMR | |
|
| ||||||
|
| Yes | Yes | Yes | Yes | Yes | Yes |
| Scoring method | Alphabetical | Numerical | Numerical | Numerical or alphabetical | Numerical | Numerical |
| Score ranking | A, B, C |
|
| [ | [0–5] |
|
| Sum of individual criterion or item scores | Yes | No | No | Dependingof the call | No | Yes |
| Decision of funding based on proposals score | Yes, A : | Yes 1, exceptional;2, outstanding; 3, excellent; 4, very good; 5, good; 6, satisfactory; 7,fair; 8, marginal; 9, poor | Yes | No | Yes, [0.0–3.4]Not fundable,[3.5–4.9] Maybe funded | Yes, |
|
| ||||||
| Scoring grid supplied | No (guidance) | No (guidance) | No (guidance) | No (guidance) | No (guidance) | No (guidance) |
| Scoring method | Numerical | Numerical | No | Numerical or alphabetical | No | Numerical |
| Score ranking | [0–5] |
|
|
| ||
| Weighting of criteria | No | No | Dependingof the call | Yes | ||
| Sum of individual criterion or item scores | No | No | Dependingof the call | Yes | ||
|
|
|
|
|
|
| |
| Guidelines about the scoringmethod | Yes, 0: notaddressed or outof scope, 1: poor,2: borderline, 3: fair to good, 4:very good, 5: excellent | Yes, 1: exceptional,2: outstanding, 3: excellent, 4: very good, 5: good, 6: satisfactory, 7:fair, 8: marginal, 9: poor | No | Yes, | ||
|
| Mandatory | Mandatory | Mandatory | Mandatory | Mandatory | Mandatory |
| Structured report | Yes | Yes | Yes | Yes | Yes | Yes |
Criteria for grant application assessment recommended by French funding organizations.
| National PHRC | Paris PHRC | North West PHRC | East PHRC | West PHRC | SouthWest PHRC (formethodologists) | South WestPHRC (for non methodologists) | Rhone Alpes PHRC | |
|
| 4 | 7 | 5 | 5 | 7 | 5 | 8 | 4 |
|
| Feasibility (3 points) | Relevance to the call (qualitative score) | Budget assessment (not scored) | Budget assessment(not scored) | Budget andpartnership (4 points) | Feasibility (16 points) | Adequacy of resources(4 points) | Feasibility (alphabetical score) |
| Methodology (3 points) | Ethical and legal considerations (alphabetical score) | Ethical considerations(4 points) | Ethical considerations (not scored) | Ethics (bad, good,very good) | FinancialConsiderations(4 points) | Ethics (not scored) | General information (alphabetical score) | |
| Originality (3 points) | Feasibility(qualitative score) | Feasibility (4 points) | Feasibility (5 points) | Feasibility (4 points) | Methodology(20 points) | Feasibility(4 points) | Methodology (alphabetic score) | |
| Usefulness (3 points) | Financial considerations (qualitative score) | Methodology (4 points) | Methodology(4 points) | Methodology of the study (4 points) | Objectives and hypotheses (8 points) | Methodology (4 points) | Scientific rationale (alphabetical score) | |
| Methodology (qualitative score) | Originality (4 points) | Originality (5 points) | Originality andimpact (4 points) | Perspectives (8 points) | Originality(4 points) | |||
|
|
|
|
|
|
|
|
| |
| Originality of the expected result (qualitative score) | Relevance of the subject(4 points) | Relevance of thesubject (5 points) | Quality and monitoring (bad, good, very good) | Prior publications(4 points) | ||||
| Usefulness of the expected result (qualitative score) | Relevance (4 points) | Quality of writing(4 points) | ||||||
| Usefulness (4 points) |
Criteria recommended for grant application assessment by one French and five international funding organizations.
| ANR | NIH | MRC | ESF | CIHR | NHMR | |
|
| 6 | 7 | 6 | 5 | 5 | 3 |
|
| Global impact of the proposal (5 points) | Approach (9 points) | Ethics andresearch governance | Applicant(s) (numerical or alphabetical) | Applicant(s) | Scientific quality (50%) |
| Mobilization ofresources (5 points) | Budget (not scored) | Importance | Budget (numerical or alphabetical) | Environment forthe research | Significance and innovation (25%) | |
| Project management(5 points) | Environment(9 points) | Justification of resources requested | Relevance and impact of the proposed research (numerical or alphabetical) | Impact for the research | Track record (25%) | |
| Quality of the consortium (5 points) | Innovation (9 points) | Other considerations (collections of human material, DNA, etc.) | Research environment (numerical or alphabetical) | Originality of the proposal | ||
| Relevance of the proposal to the call(5 points) | Investigator(s) (9 points) | Risks of research misuse | Scientific quality (numerical or alphabetical) | Research approach | ||
| Technical and scientific quality (5 points) | Other criteria according to thescope ofthe grant | Scientificpotential (environment, research plans) | ||||
| Significance (9 points) |
Typology of assessment criteria derived from our sample of calls for proposals.
| Domains | Number of calls (N = 14) |
|
|
|
| Duration of the project | 1 |
| Relevance of the proposal to the scope of the call | 2 |
| Relevance of the applicant’s characteristics to the scope of the call | 2 |
|
|
|
| Usefulness of the research for patients | 9 |
| Usefulness of the research for clinical practice | 8 |
| Relevance of the question and study concept to improving public health or scientific knowledge | 11 |
| Literature review on the scientific and medical context | 5 |
| Existence of preliminary studies | 2 |
| Need for research in this area | 1 |
| Existence of competing studies | 1 |
|
|
|
| Potential for providing original data not available in the literature | 3 |
| Potential for changing medical practice | 1 |
| Potential for international publications | 1 |
| Robust plan for disseminating the results | 3 |
| Potential fundamental outcomes in the science and/or practice of clinical medicine or public health or fundamental changes in health policy | 2 |
| Potential creation of new knowledge | 1 |
| Potential change of the concepts, methods, technologies, treatments, services, or preventive interventions that drive this field | 1 |
| Potential for opening new scientific and technical perspectives | 4 |
| Potential new understanding of a topic | 1 |
|
|
|
| Proposal innovative and original with respect to the technical and scientific aspects | 5 |
| Use or improvement of novel theoretical concepts, approaches, or methodologies, instrumentation or interventions | 1 |
| Potential for creation of new ideas or direction of research | 1 |
|
|
|
| Clarity of the objectives of the study | 5 |
| Clarity of the rationale | 1 |
| Adequacy of the design and methods to the objective | 8 |
| Relevance of inclusion criteria | 5 |
| Relevance of noninclusion criteria | 5 |
| Relevance of randomization methods | 2 |
| Sample size estimation | 4 |
| Definition of stopping rules | 2 |
| Relevance of assessment criteria | 6 |
| Quality of data-management | 2 |
| Relevance of statistical analysis | 5 |
| Quality of pharmaceutical manufactures | 1 |
| Methodological quality of the study design | 3 |
| Competitiveness of the study design | 1 |
|
|
|
|
| |
| Recruitment feasibility | 5 |
| Description of the acts and sequences of the research | 2 |
| Evaluation of risks and problems of feasibility | 3 |
| Realistic time frame | 6 |
| Description of the management of adverse events | 2 |
| Description of pharmaceutical considerations | 3 |
| Description of data management methods | 2 |
| Quality of budget assessment | 1 |
| Feasibility of the approach | 3 |
| Involvement of industry if needed | 1 |
| Control of methods employed in the proposal | 2 |
| Mobilization of human and logistic resources | 4 |
| No competitive proposals | 1 |
| In case of proof of concept research, feasibility of further research projects | 1 |
|
| |
| Quality of collaborations | 10 |
| Complementarity of collaborations | 8 |
| Prior publications of the applicant | 4 |
| Track record of the applicant | 2 |
| Relevance of the applicant (training and experience) | 2 |
| Relevance of the co-investigators (training and experience) | 1 |
| Relevance of the research field in the work of the applicant | 4 |
|
| |
| Adequacy of the research location | 4 |
| Adequacy of the team and the research environment | 4 |
| Involvement in the field of the research | 2 |
| Mobility and career development aspects | 1 |
|
|
|
| Calendar and schedule of the research | 2 |
| Time requested adequate | 1 |
| Description of supplementary funds | 2 |
| Description of resource allocations | 4 |
| Adequacy of resources | 6 |
| Description of collaborations | 1 |
| Good value for money in terms of the resources being requested | 1 |
|
|
|
| Assessment of the patient benefit-risk ratio | 2 |
| Description of patient consent forms and information | 2 |
| Description of patient follow-up | 1 |
| Ethical review and research governance clear and acceptable | 1 |
| Risk of research misuse addressed | 1 |
|
|
|
| Global quality of writing | 1 |
| Arrangements for promotion of the public understanding of science | 1 |
Characteristics of the 65 reviewers who participated in the qualitative study.
| Characteristics | N | N (%) | Internal reviewers (n = 38) | External reviewersc (n = 27) |
|
| 59 | |||
| 30–39 | 1 (1) | 0 | 1 | |
| 40–49 | 27 (46) | 18 | 9 | |
| 50–59 | 24 (41) | 10 | 14 | |
| 60–69 | 7 (12) | 5 | 2 | |
|
| ||||
| Male | 48 (74) | 29 | 19 | |
| Female | 17 (26) | 9 | 8 | |
|
| ||||
| Paris area | 45 (69) | 31 | 14 | |
| Rest of the country | 20 (31) | 7 | 13 | |
|
| ||||
| Medicine | 37 (32) | 14 | 7 | |
| Surgery | 5 (8) | 2 | 3 | |
| Methodology | 10 (15) | 9 | 1 | |
| Psychiatry | 3 (5) | 1 | 2 | |
| Obstetrics and gynecology | 2 (3) | 1 | 1 | |
| Biology | 17 (26) | 8 | 9 | |
| Anesthesia | 5 (8) | 2 | 3 | |
| Other | 2 (3) | 1 | 1 | |
|
| ||||
| Senior academic doctor | 60 (92) | 37 | 23 | |
| Junior academic doctor | 0 (0) | 0 | 0 | |
| Non-academic doctor | 5 (8) | 1 | 4 | |
|
|
| |||
| 0–2 | 13 (20) | 11 | 2 | |
| 3–5 | 21 (32) | 9 | 12 | |
| >5 | 19 (29) | 6 | 13 | |
| Unknown | 12 (19) | 12 | 0 |
Reviewers’ perceptions about assessment criteria.
| Perceptions | All reviewers (N = 65) | Internal reviewers (n = 38) | External reviewers (n = 27) |
|
| |||
| Every criterion is important in the assessment process | 12 | 5 | 7 |
| No concern about the importance of assessment criteria | 19 | 17 | 2 |
| One or several assessment criteria are important for the review | 34 | 17 | 18 |
|
| |||
| Originality | 12 | 5 | 7 |
| Methodology | 10 | 5 | 5 |
| Scientific interest | 5 | 3 | 2 |
| Feasibility | 4 | 1 | 3 |
| Originality and scientific interest of identical importance | 1 | 0 | 1 |
| Methodology and feasibility of identical importance | 1 | 1 | 0 |
| Depends on the proposal | 1 | 1 | 0 |